GlassScriptPhysician profile
Charles Pruitt
NPI 1700978889
$545.66
in general payments reported to CMS, 2019-2025
14 companies · $169 in 2025
The $169 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $155 · 2020: $27.23 · 2021: $53.49 · 2022: $29.07 · 2023: $28.53 · 2024: $84.12 · 2025: $169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $281.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $182.37 | 2019-2025 | Jardiance, Ofev |
| Abbvie INC. | $57.82 | 2025 | |
| Lilly USA, LLC | $55.32 | 2019-2024 | |
| Novo Nordisk INC | $43.81 | 2019-2023 | Rybelsus, Ozempic |
| Merck Sharp & Dohme LLC | $29.68 | 2019 | |
| Astellas Pharma US INC | $26.61 | 2019 | |
| Biogen, INC. | $26.35 | 2020-2021 | |
| Sunovion Pharmaceuticals INC. | $26.02 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $19.78 | 2025 | Austedo Xr |
| Glaxosmithkline, LLC. | $18.90 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.48 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.22 | 2019 | |
| Sanofi-Aventis U.S. LLC | $15.11 | 2023 | |
| Axsome Therapeutics, INC. | $13.19 | 2025 | Auvelity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Pruitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.